Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
DAVIDSON & GARRARD INC (CIK 1082482) reported $424.6M across 178 reported positions in its SEC 13F filing for 2017-09-30. Largest positions: AAPL ($18.6M, 4.39%), TMO ($10.1M, 2.38%), ABBV ($10.1M, 2.37%), IVV ($10.0M, 2.36%), PFF ($9.6M, 2.26%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AAPL | Apple Inc. | $18.6M | 4.39% | 120,884 | Trimmed |
| 2 | TMO | Thermo Fisher | $10.1M | 2.38% | 53,394 | Trimmed |
| 3 | ABBV | AbbVie Inc. | $10.1M | 2.37% | 113,099 | Trimmed |
| 4 | IVV | iShr S&P 500 Index | $10.0M | 2.36% | 39,619 | Added |
| 5 | PFF | iShr S&P US Pfd ETF | $9.6M | 2.26% | 247,524 | Added |
| 6 | JPM | JPMorgan Chase | $9.1M | 2.14% | 95,264 | Trimmed |
| 7 | BAC | Bank of America | $8.8M | 2.08% | 349,104 | Trimmed |
| 8 | VZ | Verizon Comm. | $8.6M | 2.02% | 173,486 | Trimmed |
| 9 | T | AT&T Inc. | $8.3M | 1.95% | 210,862 | Trimmed |
| 10 | MCHP | Microchip Tech. | $8.0M | 1.88% | 88,753 | Trimmed |
| 11 | CVS | CVS Health | $7.9M | 1.87% | 97,527 | Trimmed |
| 12 | GE | General Electric Co | $7.9M | 1.85% | 324,890 | Added |
| 13 | META | $7.7M | 1.82% | 45,214 | Added | |
| 14 | BDX | Becton Dickinson | $7.7M | 1.82% | 39,434 | Trimmed |
| 15 | MSFT | Microsoft Corp. | $7.6M | 1.80% | 102,666 | Trimmed |
| 16 | PEP | PepsiCo, Inc. | $6.9M | 1.63% | 62,238 | Trimmed |
| 17 | XOM | Exxon Mobil Corp | $6.9M | 1.62% | 83,805 | Added |
| 18 | VIG | Vanguard Dividend App. ETF | $6.7M | 1.57% | 70,243 | Added |
| 19 | BA | Boeing Company | $6.6M | 1.57% | 26,150 | Trimmed |
| 20 | ENB | Enbridge, Inc. | $6.2M | 1.47% | 149,159 | Trimmed |
| 21 | IJH | iShr S&P Midcap 400 | $6.1M | 1.44% | 34,158 | Added |
| 22 | INTC | Intel Corporation | $6.0M | 1.42% | 157,874 | Trimmed |
| 23 | MRK | Merck & Co. Inc. | $5.7M | 1.35% | 89,763 | Added |
| 24 | JNJ | Johnson & Johnson | $5.7M | 1.34% | 43,720 | Trimmed |
| 25 | PG | Procter & Gamble | $5.7M | 1.34% | 62,414 | Trimmed |
Source: SEC Form 13F filings · as of 2017-09-30